No abstract available
MeSH terms
-
Alzheimer Disease / immunology*
-
Alzheimer Disease / prevention & control
-
Alzheimer Disease / therapy*
-
Amyloid beta-Peptides / adverse effects
-
Amyloid beta-Peptides / antagonists & inhibitors
-
Amyloid beta-Peptides / immunology*
-
Amyloid beta-Peptides / therapeutic use
-
Animals
-
Antibodies / immunology
-
Antibodies / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
Disease Models, Animal
-
Humans
-
Immunization, Passive / methods*
-
Immunization, Passive / trends
-
Immunotherapy, Active / methods*
-
Immunotherapy, Active / trends
-
Meningoencephalitis / chemically induced
-
Mice
-
Mice, Transgenic
-
Peptide Fragments / immunology
-
Treatment Outcome
-
Vaccines / adverse effects
-
Vaccines / therapeutic use
Substances
-
AN-1792
-
Amyloid beta-Peptides
-
Antibodies
-
Antibodies, Monoclonal
-
Peptide Fragments
-
Vaccines